Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Reggio Emilia
Clinical trial register · Italy

Clinical Trials in Reggio Emilia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Reggio Emilia 32 Modena 7 Milan 6 Bologna 5 Parma 3
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Azienda USL Reggio Emilia - IRCCS32 AstraZeneca8 Novartis Pharmaceuticals6 IRCCS Azienda Ospedaliero-Universitaria di Bologna5 Amgen4 Clear sponsor filter
Site location
Reggio Emilia32 Modena7 Milan6 Bologna5 Parma3
All 34 locations
Target enrolment
to

Trials with a site in Reggio Emilia

32 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Azienda USL Reggio Emilia - IRCCS
Not applicable
160
Reggio Emilia
2027-12
Not yet open
Azienda USL Reggio Emilia - IRCCS
Observational
210
Bari, Bologna, Ferrara, Meldola, Milan, Modena, Naples, Reggio Emilia
2026-08-30
Recruiting
HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT
NCT07579065Hematologic Neoplasm, Hematopoietic Stem Cell Transplantation, Survivorship, Cancer Survivorship
Azienda USL Reggio Emilia - IRCCS
Not applicable
40
Reggio Emilia
2026-06
Active, closed
Low Dose Radiotherapy in Primary Indolent Cutaneous B-cell Lymphoma
NCT07310745Primary Indolent Cutaneous B-cell Lymphoma
Azienda USL Reggio Emilia - IRCCS
Observational
52
Reggio Emilia
2025-12-18
Recruiting
Azienda USL Reggio Emilia - IRCCS
Observational
50
Reggio Emilia
2025-09-01
Recruiting
A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia
NCT07061145Chronic Myelocytic Leukemia, Erectile Dysfunctions, CVD - Cardiovascular Disease, Tyrosine Kinase Inhibitor
Azienda USL Reggio Emilia - IRCCS
Observational
350
Reggio Emilia
2025-07-01
Recruiting
The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease
NCT06795815Leukemia, Multiple Mieloma, Advanced Solid Tumors, Lymphoma
Azienda USL Reggio Emilia - IRCCS
Not applicable
75
Reggio Emilia
2025-06-30
Recruiting
Centralization and Oncologic Outcomes in Ovarian Cancer
NCT07075939Epithelial Ovarian Cancer, Ovarian Neoplasms, Advanced Ovarian Cancer
Azienda USL Reggio Emilia - IRCCS
Observational
200
Carpi, Mirandola, Pavullo nel Frignano, Sassuolo, Vignola, Reggio Emilia, Modena
2025-06-27
Recruiting
Azienda USL Reggio Emilia - IRCCS
Observational
190
Reggio Emilia
2025-06-17
Recruiting
Azienda USL Reggio Emilia - IRCCS
Phase 2
56
Reggio Emilia
2025-05-26
Recruiting
Azienda USL Reggio Emilia - IRCCS
Observational
30
Reggio Emilia
2025-04-01
Recruiting
Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution
NCT07214324Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM), Multiple Myeloma (MM)
Azienda USL Reggio Emilia - IRCCS
Observational
60
Bologna, Catania, Palermo, Reggio Emilia
2025-03-17
Recruiting
Azienda USL Reggio Emilia - IRCCS
Not applicable
2,200
Reggio Emilia
2025-02-01
Recruiting
Azienda USL Reggio Emilia - IRCCS
Observational
40
Modena, Padova, Reggio Emilia, Roma
2024-11-02
Recruiting
Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD
NCT07187843Parkinson Disease, Parkinsonian Disorders, Brain Disease, Basal Ganglia Diseases
Azienda USL Reggio Emilia - IRCCS
Observational
150
Reggio Emilia
2024-09-04
Recruiting
Multidimensional Omics Analysis in Malignant Pleural Mesothelioma
NCT07561190Malignant Pleural Mesothelioma (MPM)
Azienda USL Reggio Emilia - IRCCS
Observational
300
Catania, Naples, Reggio Emilia, Roma
2024-08-30
Recruiting
Multicenter Retrospective Observational Study of Relapsed Diffuse Large B-Cell Lymphoma Presenting as Indolent Lymphoma
NCT06822829Diffuse Large B Cell Lymphoma (DLBCL), Indolent B-Cell Lymphomas, Indolent B Cell Lymphoma
Azienda USL Reggio Emilia - IRCCS
Observational
50
Reggio Emilia
2024-08-19
Recruiting
Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma
NCT06749600Primary Ovarian Leiomyosarcoma
Azienda USL Reggio Emilia - IRCCS
Observational
30
Modena, Parma, Reggio Emilia, Avellino, Catania, Milan, Monza, Naples
2024-06-14
Recruiting
Azienda USL Reggio Emilia - IRCCS
Observational
4,500
Bologna, Modena, Reggio Emilia
2024-02-01
Recruiting
Azienda USL Reggio Emilia - IRCCS
Observational
3,000
Brindisi, Milan, Reggio Emilia, Trento
2023-11-23
Active, closed
Azienda USL Reggio Emilia - IRCCS
Not applicable
31
Reggio Emilia
2023-03-10
Active, closed
Azienda USL Reggio Emilia - IRCCS
Not applicable
16
Reggio Emilia
2022-07-07
Recruiting
Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
NCT06822855Classical Hodgkin Lymphoma, Classical Hodgkin Lymphoma Recurrent, Classical Hodgkin Lymphoma Refractory
Azienda USL Reggio Emilia - IRCCS
Observational
755
Milan, Reggio Emilia, Avellino, Brescia, Padova, Palermo, Perugia, Piacenza
2022-06-23
Recruiting
Azienda USL Reggio Emilia - IRCCS
Not applicable
282
Bologna, Genova, Milan, Modena, Reggio Emilia
2021-11-18
Recruiting
Azienda USL Reggio Emilia - IRCCS
Observational
180
Reggio Emilia
2021-11-17
Recruiting
New AI-based Technologies in Nuclear Medicine
NCT07174089Patients Undergoing PET/CT Investigation or Nuclear Medicine Therapy
Azienda USL Reggio Emilia - IRCCS
Observational
1,500
Reggio Emilia
2021-07-30
Active, closed
Azienda USL Reggio Emilia - IRCCS
Observational
700
Reggio Emilia, Bologna, Ferrara, Forlì, Modena, Parma, Rimini
2021-05-10
Active, closed
Azienda USL Reggio Emilia - IRCCS
Phase 3
280
Coppito, Guastalla, Reggio Emilia, Mirano
2021-04-30
Recruiting
Endoscopic Resection of Gastrointestinal Neoplasms
NCT04780256Endoscopic Mucosal Resection, Endoscopic Submucosal Dissection, Gastric Neoplasm, Colonic Neoplasms
Azienda USL Reggio Emilia - IRCCS
Observational
2,000
Reggio Emilia
2021-03-15
Active, closed
Biomarkers of Cancer-Associated Myositis
NCT06808672Dermatomyositis
Azienda USL Reggio Emilia - IRCCS
Observational
50
Bari, Reggio Emilia
2019-06-13
Active, closed
Bioimpedance Analysis in Perioperative Assessment in Thoracic Surgery
NCT06796816Lung Resection, Adenocarcinoma of Lung
Azienda USL Reggio Emilia - IRCCS
Not applicable
1,000
Reggio Emilia
2019-04-01
Active, closed
Azienda USL Reggio Emilia - IRCCS
Not applicable
10,156
Reggio Emilia, Milan, Verona
2019-03-01
Rows per page Showing 1–32 of 32
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/reggio-emilia

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 32 of those studies with a site in Reggio Emilia that also match the filters currently applied.

How many clinical trials are recruiting in Reggio Emilia?

22 of the 32 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 2 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Reggio Emilia), 32 studies
PhaseStudiesRecruitingShare
Observational211765.6%
Not applicable9428.1%
Phase 2113.1%
Phase 3103.1%

Most active sponsors

Lead sponsors with the most studies (Reggio Emilia)
Lead sponsorStudiesRecruiting
Azienda USL Reggio Emilia - IRCCS3222
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.